Announcements Trials

Browse Landscape

Phase

Phase 2 31 Phase 3 16 Phase 1/2 5 Phase 2/3 4 Phase 4 2 Phase NA 1 Phase 1 1

Status

Completed 12 Terminated 4 Active not recruiting 4 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 119 Specimen Handling 104 pembrolizumab 102 Magnetic Resonance Spectroscopy 96 fludarabine 92 Biopsy 79 Injections 53 Nivolumab 41 venetoclax 40 Bevacizumab 40 Fluorouracil 38 Paclitaxel 37 Cisplatin 36 Cetuximab 35 Carboplatin 35 Gemcitabine 31 fludarabine phosphate 30 Radiotherapy 30 Oxaliplatin 30 Leucovorin 28 Immunotherapy, Adoptive 25 Drug Therapy 25 Ipilimumab 24 Azacitidine 23 Irinotecan 21 130-nm albumin-bound paclitaxel 21 tislelizumab 20 Temozolomide 20 Radiation 20 atezolizumab 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Recruiting × pertuzumab × Clear all

NCT06162559 2024-01-11

TRAIN-4

The Netherlands Cancer Institute

Phase 1 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡